Validation of the pharmacoeconomic model of emtricitabin/ rilpivirine/ tenofovir (eviplera) inclusion in highly active antiretroviral therapy of HIV/AIDS in the Russian Federation
2006 ◽
Vol 20
(9)
◽
pp. 637-648
◽
2011 ◽
Vol 24
(1)
◽
pp. 79-88
◽
Keyword(s):
2012 ◽
Vol 18
(6)
◽
pp. 356-360
◽
Keyword(s):
Keyword(s):
1999 ◽
Vol 13
(9)
◽
pp. 535-544
◽
2008 ◽
Vol 12
(2)
◽